| 今开：0.0 | 昨收：1.0 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.2347584E7 |
$Pluristem疗法(PSTI)$ 8-K Current report, items 5.03, 8.01, and 9.01 Accession Number: 0001213900-22-041096 Act: 34 Size: 3 MB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-039009 Act: 34 Size: 204 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, items 5.02 and 5.07 Accession Number: 0001213900-22-034605 Act: 34 Size: 209 KB 网页链接
$Pluristem疗法(PSTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-22-024864 Act: 34 Size: 3 MB 网页链接
$Pluristem疗法(PSTI)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-22-021895 Act: 34 Size: 1 MB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-014625 Act: 34 Size: 196 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-010987 Act: 34 Size: 197 KB 网页链接
$Pluristem疗法(PSTI)$ 8-K Current report, item 8.01 Accession Number: 0001213900-22-009545 Act: 34 Size: 203 KB 网页链接
$Pluristem疗法(PSTI)$ 内部交易: 2022-02-10,Director,Aberman Zami ,买入,80616普通股, $1.80
$Pluristem疗法(PSTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-22-007471 Size: 6 KB 网页链接